A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.
Oral Oncol
; 73: 138-146, 2017 10.
Article
in En
| MEDLINE
| ID: mdl-28939066
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Head and Neck Neoplasms
/
Antibodies, Monoclonal
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Oral Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Country of publication: